Status:
COMPLETED
Safety of a New Security Device in Patients With Implanted Cardiac Electronic Devices
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Collaborating Sponsors:
Bayerisches Staatsministerium für Wirtschaft
R & S GmbH und Co KG
Conditions:
Electromagnetic Interference
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with implantable cardiac electronic devices will be exposed to a new safety device and evaluated for potential electromagnetic interference.
Detailed Description
Patients with implanted pacemakers or defibrillators will undergo a screening procedure with an innovative security device. Evaluation will be made with respect to the occurrence of interference.
Eligibility Criteria
Inclusion
- implantable pacemaker or defibrillator in situ
Exclusion
- malfunction of implantable pacemaker or defibrillator
- low battery voltage of implanted cardiac electronic device
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
379 Patients enrolled
Trial Details
Trial ID
NCT03264222
Start Date
May 1 2017
End Date
October 31 2018
Last Update
August 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deutsches Herzzentrum München
Munich, Bavaria, Germany, 80636